{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:04:20Z","timestamp":1791475460240,"version":"4.3.4"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,3,15]]},"DOI":"10.2169\/internalmedicine.3298-19","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T22:06:53Z","timestamp":1574978813000},"page":"811-815","source":"Crossref","is-referenced-by-count":17,"title":["Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels"],"prefix":"10.2169","volume":"59","author":[{"given":"Hiroyuki","family":"Koyama","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Kakoi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Ohata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Child Neurology, Okayama University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Aotani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenro","family":"Imaeda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"},{"name":"Department of Endocrinology and Diabetes, Nagoya City West Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Weiss MJ, Cole DE, Ray K, et al. A missense mutation in the human liver\/bone\/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci U S A 85: 7666-7669, 1988.","DOI":"10.1073\/pnas.85.20.7666"},{"key":"2","unstructured":"2. Rockman-Greenberg C. Hypophosphatasia. Pediatr Endocrinol Rev 10: 380-388, 2013."},{"key":"3","unstructured":"3. Bianchi ML. Hypophosphatasia: an overview of the disease and its treatment. Osteoporosis Int 12: 2743-2757, 2015."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Taketani T, Onigata K, Kobayashi H, Mushimoto Y, Fukuda S, Yamaguchi S. Clinical and genetic aspects of hypophosphatasia in Japanese patients. Arch Dis Child 99: 211-215, 2014.","DOI":"10.1136\/archdischild-2013-305037"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Schmidt T, Mussawy H, Rolvien T, et al. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int 28: 2653-2662, 2017.","DOI":"10.1007\/s00198-017-4087-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA. Clinical spectrum of hypophosphatasia diagnosed in adults. Bone 54: 21-27, 2013.","DOI":"10.1016\/j.bone.2013.01.024"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483, 1992.","DOI":"10.1097\/00005650-199206000-00002"},{"key":"8","unstructured":"8. Whyte MP, Zhang F, Wenkert D, et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone 75: 229-239, 2015."},{"key":"9","unstructured":"9. Whyte MP. Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges. J Bone Miner Res 32: 667-675, 2017."},{"key":"10","unstructured":"10. Japan Intractable Diseases Information Center. Hypophosphatasia [Internet]. [cited 2019 Sep 9]. Available from: http:\/\/www.nanbyou.or.jp\/entry\/4565 (in Japanese)"},{"key":"11","unstructured":"11. Weber TJ, Sawyer EK, Moseley S, Odrljin T, Kishnani PS. Burden of disease in adult patients with hypophosphatasia: results from two patient-reported surveys. Metabolism 65: 1522-1530, 2016."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Maman E, Borderie D, Roux C, Briot K. Absence of recognition of low alkaline phosphatase level in a tertiary care hospital. Osteoporos Int 27: 1251-1254, 2016.","DOI":"10.1007\/s00198-015-3346-0"},{"key":"13","unstructured":"13. Akiyama T, Kubota T, Ozono K, et al. Pyridoxal 5&apos;-phosphate and related metabolites in hypophosphatasia: effects of enzyme replacement therapy. Mol Genet Metab 125: 174-180, 2018."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Komaru K, Ishida Y, Amaya Y, Goseki-Sone M, Orimo H, Oda K. Novel aggregate formation of a frame-shift mutant protein of tissue-nonspecific alkaline phosphatase is ascribed to three cysteine residues in the C-terminal extension. Retarded secretion and proteasomal degradation. FEBS J 272: 1704-1717, 2005.","DOI":"10.1111\/j.1742-4658.2005.04597.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Orimo H, Goseki-Sone M, Inoue M, Tsubakio Y, Sakiyama T, Shimada T. Importance of deletion of T at nucleotide 1559 in the tissue-nonspecific alkaline phosphatase gene in Japanese patients with hypophosphatasia. J Bone Miner Metab 20: 28-33, 2002.","DOI":"10.1007\/s774-002-8443-4"},{"key":"16","unstructured":"16. Watanabe A, Karasugi T, Shimada T, et al. Prevalence of c.1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasia in Japanese and effects of the mutation on heterozygous carriers. J Hum Genet 56: 166-168, 2011."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Taillandier A, Domingues C, Dufour A, et al. Genetic analysis of adults heterozygous for ALPL mutations. J Bone Miner Metab 36: 723-733, 2018.","DOI":"10.1007\/s00774-017-0888-6"},{"key":"18","unstructured":"18. Shapiro JR, Lewiecki EM. Hypophosphatasia in adults: clinical assessment and treatment considerations. J Bone Miner Res 32: 1977-1980, 2016."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kishnani PS, Rush ET, Arundel P, et al. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab 122: 4-17, 2017.","DOI":"10.1016\/j.ymgme.2017.07.010"},{"key":"20","doi-asserted-by":"crossref","first-page":"e85971","DOI":"10.1172\/jci.insight.85971","volume":"1","author":"MP Whyte","year":"2016","unstructured":"20. Whyte MP, Madson KL, Phillips D, et al. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight 1: e85971, 2016.","journal-title":"JCI Insight","ISSN":"https:\/\/id.crossref.org\/issn\/2379-3708","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/jbm4.10052","volume":"2","author":"P Klidaras","year":"2018","unstructured":"21. Klidaras P, Severt J, Aggers D, Payne J, Miller PD, Ing SW. Fracture healing in two adult patients with hypophosphatasia after asfotase alfa therapy. JBMR Plus 2: 304-307, 2018.","journal-title":"JBMR Plus","ISSN":"https:\/\/id.crossref.org\/issn\/2473-4039","issn-type":"print"},{"key":"22","unstructured":"22. Freitas TQ, Franco AS, Pereira RMR. Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: case report. Medicine (Baltimore) 97: e13210, 2019."},{"key":"23","unstructured":"23. Kitaoka T, Tajima T, Nagasaki K, et al. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: results from a Japanese clinical trial. Clin Endocrinol (Oxf) 87: 10-19, 2017."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Whyte MP, Greenberg CR, Salman NJ, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366: 904-913, 2012.","DOI":"10.1056\/NEJMoa1106173"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/6\/59_3298-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T03:40:50Z","timestamp":1584762050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/6\/59_3298-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,15]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3298-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,15]]}}}